ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
Business deals

Top Vietnamese drugmaker DHG draws fresh Japanese investment

Removal of ownership limit opens door to even bigger stake by Taisho

Vietnam’s pharmaceutical market is attracting investment from outside the country, but drug distribution remains off-limits to foreign ownership.   © Reuters

HO CHI MINH CITY -- Taisho Pharmaceutical Holdings is poised to raise its stake in DHG Pharmaceutical for the second time since June, cementing the Japanese group's position as the second-largest shareholder in the leading Vietnamese drugmaker.

The purchase would lift the Japanese maker of energy drinks and hair loss treatments to a 32% share from 24.94%. Vietnamese wealth fund State Capital Investment Corp. ranks first, at 43.3%.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more